AOL

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...
Seeking Alpha

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced plans to initiate a patient data registry for ...
Becker's Hospital Review

FDA warns of injury risk with catheter system

The FDA issued a warning regarding the Rotarex Atherectomy System, a device used to break up and remove the thrombus from peripheral arteries. Bard Peripheral Vascular, a subsidiary of Becton, ...
Healio

Greater plaque reduction, luminal gain with directional vs. orbital atherectomy system

Please provide your email address to receive an email when new articles are posted on . In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel ...
EurekAlert!

Treating severe calcification with an atherectomy device does not improve cardiac stenting outcomes, study finds

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...